Status:
ACTIVE_NOT_RECRUITING
Myoslow Lens Study to Control Myopia in Children
Lead Sponsor:
Crystal Optic
Conditions:
Myopia
Eligibility:
All Genders
6-12 years
Phase:
PHASE4
Brief Summary
A Prospective, randomized, controlled double masked trial to assess the performance of Myoslow lens in slowing myopia progression in children. The following study measures will be assessed: * Demogr...
Eligibility Criteria
Inclusion
- Children, 6-12 years old
- Spherical Equivalence Refraction (SER): -1.00 to -5.00 Diopter (D).
- Astigmatism and anisometropia of 1.50 D or less.
- Best Corrected Visual Acuity (BCVA) (6 / 7.5) or higher.
Exclusion
- Eye and systemic disorders.
- Previously treated for myopia
Key Trial Info
Start Date :
November 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2025
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT06553404
Start Date
November 24 2022
End Date
November 1 2025
Last Update
August 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba MC
Ramat Gan, Israel